Moderna considering manufacturing COVID-19 vaccines in Japan - media

JCR Pharmaceuticals

21/05/2021 05:43

TOKYO, May 21 (Reuters) - Moderna Inc  MRNA.O  is
considering manufacturing its COVID-19 vaccine in Japan, the
Nikkei newspaper reported on Friday, citing an interview with
the company's chief executive. 
    The company is looking into making the vaccine in Asia,
including in Japan, Stephane Bancel told Nikkei. 
    Takeda Pharmaceutical Co  4502.T  in Japan has been handling
importation and regulatory filing for the vaccine, which the
health ministry officially approved on Friday.  urn:newsml:reuters.com:*:nL2N2N8043

 (Reporting by Chang-Ran Kim and Rocky Swift; Editing by Tom
Hogue)
 ((rocky.swift@thomsonreuters.com;))